Mallinckrodt (MNK) Warns of Chapter 11 Filing

With earnings, Mallinckrodt (NYSE: MNK) said it continues to work to resolve outstanding issues related to opioids, Acthar Gel, and other risks, as well as address overall debt levels, and is considering with its external advisors all options to address legal and financial challenges. While no final determination has been made, it is possible that Mallinckrodt plc and most of its subsidiaries could file for Chapter 11 reorganization in the near term.

You May Also Be Interested In

• Royal Caribbean to acquire 50% stake in Sandals Resorts for $3 billion
• Garg Group claims 46% shareholder backing in Better board fight
• TriSalus Life Sciences receives FDA clearance for TriNav Advance device